You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NSC-716051

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Uterine Cancer Trial in Houston (Imatinib Mesylate, Paclitaxel)

Terminated
Has Results
  • Uterine Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 26, 2020

Gastrointestinal Stromal Tumor Trial in Philadelphia (Conventional Surgery, Imatinib Mesylate)

Completed
Has Results
  • Gastrointestinal Stromal Tumor
  • Conventional Surgery
  • Imatinib Mesylate
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 22, 2020

Pulmonary Veno Occlusive Disease Trial in Boston (Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Pulmonary Veno Occlusive Disease
  • Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
  • Boston, Massachusetts
    Boston Childrens Hospital
Jun 6, 2019

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Melanoma, Skin Tumors Trial in Houston (Imatinib mesylate (STI571))

Completed
  • Melanoma
  • Skin Neoplasms
  • Imatinib mesylate (STI571)
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Oct 30, 2018

Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelogenous Leukemia
  • Lonafarnib (SCH66336)
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    M.D. Anderson Cancer Center
Nov 6, 2018

Dementia Trial in Málaga (Nordic Sensi Chair)

Completed
  • Dementia
  • Nordic Sensi Chair
  • Málaga, Spain
    Instituto Andaluz de Neurociencia
Jan 30, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

On Craniosynostosis, Skull Malformations With Premature Fusion

Recruiting
  • Craniosynostosis
  • Craniosynostosis Network Environmental Survey
  • +6 more
  • Davis, California
  • +19 more
Jul 5, 2022

Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

From Skin Fibroblasts to Neural Stem Cells to Investigate in

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +5 more
  • Skin biopsy
  • Roma, Italy
    Mingrone Geltrude
Mar 8, 2023

NSCLC, Bone Metastases Trial in France (Denosumab-nivolumab combination)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Bone Metastases
  • Denosumab-nivolumab combination
  • Aix-en-Provence, France
  • +26 more
Jul 19, 2022

Executive Function of School-aged Children With ASD Trial in Taipei City (VR game intervention)

Recruiting
  • Executive Function of School-aged Children With ASD
  • VR game intervention
  • Taipei City, State, Taiwan
    National Taiwan Normal University
Nov 12, 2023

Brain and CNS Tumors Trial in United States (imatinib mesylate)

Completed
  • Brain and Central Nervous System Tumors
  • imatinib mesylate
  • Los Angeles, California
  • +10 more
Jun 25, 2018

Complex Post-Traumatic Stress Disorder Trial in Leatherhead (Enhanced Skills Training in Affective and Interpersonal Regulation,

Recruiting
  • Complex Post-Traumatic Stress Disorder
  • Enhanced Skills Training in Affective and Interpersonal Regulation
  • Treatment as usual
  • Leatherhead, Surrey, United Kingdom
    Combat Stress
Apr 22, 2022

Neurofibromatosis, Neurofibromas Trial in Indianapolis (Gleevec)

Completed
Has Results
  • Neurofibromatosis
  • Neurofibromas
  • Indianapolis, Indiana
    Riley Hospital for Children
Jun 2, 2017

Parkinson Disease Trial in Rouen (Directional and single ring STN-DBS on gait)

Unknown status
  • Parkinson Disease
  • Directional and single ring STN-DBS on gait
  • Rouen, France
    CHU de ROUEN
Jun 2, 2020

Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma Trial in United States (imatinib mesylate,

Completed
Has Results
  • Adult Grade I Meningioma
  • +5 more
  • imatinib mesylate
  • +2 more
  • Los Angeles, California
  • +6 more
May 2, 2017

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory

Terminated
Has Results
  • Adenocarcinoma of the Colon
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 29, 2019

Child Behavior, Autism Spectrum Disorder, Psychiatric Hospitalization Trial (Activity)

Completed
  • Child Behavior
  • +3 more
  • Activity
  • (no location specified)
May 16, 2019

Mesothelioma Trial in Houston (Cisplatin, Imatinib Mesylate, Pemetrexed)

Completed
  • Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 16, 2015

Pulmonary Hypertension Trial in Indianapolis (Gleevec)

Terminated
Has Results
  • Pulmonary Hypertension
  • Indianapolis, Indiana
    Indiana University School of Medicine; Riley Hospital for Childr
Sep 28, 2015

Parkinson Disease Trial in Suzhou (human neural stem cell)

Unknown status
  • Parkinson Disease
  • human neural stem cell
  • Suzhou, Jiangsu, China
    Department of Neurology, Second Affiliated Hospital of Soochow U
Sep 13, 2017